Clinical Trial Update: Arsenic Trioxide in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This update reports the completion of a phase 2 trial evaluating arsenic trioxide for locally advanced or metastatic non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Trisenox (arsenic trioxide)

Snippet

Sponsor: The University of Texas Medical Branch, Galveston | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED